Literature DB >> 3976362

Evidence of subclinical extrapyramidal hemosiderosis in cystic fibrosis.

T Wongmongkolrit, R Wyszynski, C O Hershey, A W Varnes.   

Abstract

We are presenting evidence of subclinical extrapyramidal hemosiderosis in chronic cystic fibrosis (CF) by histological staining and quantitative analysis. Comparison was made between age-matched control (eight cases) and CF brains (14 cases). None of the CF patients had extrapyramidal or other focal CNS symptoms but showed an increased iron pigment, and four cases had a few dystrophic axons (DA) in pallidonigral areas. Histological stain revealed significantly increased iron pigment in pallidonigral and subthalamic nuclei (P less than 0.05, 0.01, 0.01, respectively). The pigment was located in astrocytes, macrophages, neuronal perikarya, and neuropils. The increase was directly proportional to age and numbers of DA in nucleus gracilis/cuneatus. As in previous reports [5, 22], the numbers of DA in nucleus gracilis/cuneatus were higher in CF (P less than 0.01) and varied directly with age (correlation coefficient 0.72). Quantitative analysis disclosed an upward trend of mean iron content in pallidonigral areas. Aluminum was detected in four cases of CF but not in the controls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976362     DOI: 10.1007/bf00687007

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  NEUROAXONAL DYSTROPHY IN MUCOVISCIDOSIS.

Authors:  J H SUNG
Journal:  J Neuropathol Exp Neurol       Date:  1964-10       Impact factor: 3.685

2.  Quantitative elemental analyses by plasma emission spectroscopy.

Authors:  V A Fassel
Journal:  Science       Date:  1978-10-13       Impact factor: 47.728

3.  Iron absorption in cystic fibrosis.

Authors:  O Tönz; S Weiss; H W Strahm; E Rossi
Journal:  Lancet       Date:  1965-11-27       Impact factor: 79.321

4.  Mineral composition of brains of normal and multiple sclerosis victims.

Authors:  W Craelius; R M Jacobs; A O Jones
Journal:  Proc Soc Exp Biol Med       Date:  1980-11

5.  [The absorption of iron salts in mucoviscidosis].

Authors:  S Weiss
Journal:  Arch Kinderheilkd       Date:  1966-05

6.  Dystrophic axons and spinal cord demyelination in cystic fibrosis.

Authors:  S J Cavalier; P Gambetti
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

7.  Absorption of inorganic iron- (59Fe2+) in relation to iron stores in pancreatic exocrine insufficiency due to cystic fibrosis.

Authors:  H C Heinrich; C Bender-Götze; E E Gabbe; H Bartels; K H Oppitz
Journal:  Klin Wochenschr       Date:  1977-06-15

8.  Silicon as a potential uremic neurotoxin: trace element analysis in patients with renal failure.

Authors:  C O Hershey; E S Ricanati; L A Hershey; A W Varnes; P J Lavin; W H Strain
Journal:  Neurology       Date:  1983-06       Impact factor: 9.910

9.  Increase in blood silicon concentration in patients with renal failure.

Authors:  Y Mauras; P Riberi; F Cartier; P Allain
Journal:  Biomedicine       Date:  1980-11

10.  Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport.

Authors:  A Bizzi; R C Crane; L Autilio-Gambetti; P Gambetti
Journal:  J Neurosci       Date:  1984-03       Impact factor: 6.167

View more
  2 in total

1.  Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the human brain.

Authors:  Yong Guo; Min Su; Michael A McNutt; Jiang Gu
Journal:  J Histochem Cytochem       Date:  2009-08-03       Impact factor: 2.479

2.  Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the spinal cord.

Authors:  Yong Guo; Min Su; Meng Su; Michael A McNutt; Jiang Gu
Journal:  J Neurosci Res       Date:  2009-12       Impact factor: 4.164

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.